A new research paper published on arXiv introduces a method to improve the evaluation of generative models used in drug discovery. The study highlights that current selection methods often overlook the crucial link between predicted molecular properties and actual drug exposure at a given dose. By integrating physiologically based pharmacokinetic (PBPK) simulations, the researchers found that a significant portion of shortlisted molecules failed to achieve sufficient target exposure or presented safety risks. This approach suggests that considering dose and exposure can lead to a more effective identification of promising drug candidates. AI
IMPACT Enhances the reliability of AI-driven drug discovery by incorporating pharmacokinetic simulations into candidate evaluation.
RANK_REASON Research paper published on arXiv detailing a new evaluation method for generative drug design models. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →